Jounce Therapeutics Price on March 16, 2023

JNCEDelisted Stock  USD 1.88  0.00  0.00%   
If you're considering investing in Jounce Stock, it is important to understand the factors that can impact its price. As of today, the current price of Jounce Therapeutics stands at 1.88, as last reported on the 20th of May, with the highest price reaching 1.88 and the lowest price hitting 1.88 during the day. We have found twenty-four technical indicators for Jounce Therapeutics, which you can use to evaluate the volatility of the firm. Please check out Jounce Therapeutics' Downside Deviation of 4.21, market risk adjusted performance of 0.5095, and Risk Adjusted Performance of 0.0875 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Jounce Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
JNCE
Based on monthly moving average Jounce Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jounce Therapeutics by adding Jounce Therapeutics to a well-diversified portfolio.

Jounce Therapeutics Valuation on March 16, 2023

It is possible to determine the worth of Jounce Therapeutics on a given historical date. On March 16, 2023 Jounce was worth 1.43 at the beginning of the trading date compared to the closed value of 1.56. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Jounce Therapeutics stock. Still, in general, we apply an absolute valuation method to find Jounce Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Jounce Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Jounce Therapeutics' related companies.
 Open High Low Close Volume
  1.46    1.64    1.43    1.49    29,099,397  
03/16/2023
  1.43    1.62    1.40    1.56    4,268,418  
  1.55    1.64    1.53    1.61    3,115,055  
Backtest Jounce Therapeutics  |  Jounce Therapeutics History  |  Jounce Therapeutics Valuation   PreviousNext  
Open Value
1.43
1.56
Closing Value
1.43
Upside

Jounce Therapeutics Trading Date Momentum on March 16, 2023

On March 17 2023 Jounce Therapeutics was traded for  1.61  at the closing time. The top price for the day was 1.64  and the lowest listed price was  1.53 . The trading volume for the day was 3.1 M. The trading history from March 17, 2023 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 3.21% . The trading delta at closing time against the current closing price is 19.87% .

Jounce Therapeutics Fundamentals Correlations and Trends

By evaluating Jounce Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Jounce Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Jounce financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Jounce Therapeutics Stock history

Jounce Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Jounce is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Jounce Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Jounce Therapeutics stock prices may prove useful in developing a viable investing in Jounce Therapeutics
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts. Jounce Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 137 people.

Jounce Therapeutics Stock Technical Analysis

Jounce Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Jounce Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Jounce Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Jounce Therapeutics Period Price Range

Low
March 16, 2023
0.13  9.09%
High

 1.43 

     

 1.56 

Jounce Therapeutics May 20, 2024 Market Strength

Market strength indicators help investors to evaluate how Jounce Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Jounce Therapeutics shares will generate the highest return on investment. By undertsting and applying Jounce Therapeutics stock market strength indicators, traders can identify Jounce Therapeutics entry and exit signals to maximize returns

Jounce Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Jounce Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Jounce Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Jounce to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the Jounce Therapeutics information on this page should be used as a complementary analysis to other Jounce Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in Jounce Stock

If you are still planning to invest in Jounce Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Jounce Therapeutics' history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance